D
Doc Plus
A network of Russian private clinics offering a wide range of medical services and specialists
About Doc Plus
Doc Plus emerged as a pioneering force in the Russian healthcare sector, aiming to revolutionize how medical services are accessed and delivered. Founded by a team of visionary entrepreneurs, Doc Plus set out to bridge the gap between patients and healthcare providers through technology.
In its early days, Doc Plus focused on developing a platform that would allow users to easily book medical appointments and access healthcare services from the comfort of their homes. This approach not only provided convenience but also addressed the pressing need for accessible healthcare in remote areas.
As the company grew, it attracted significant attention from investors, leading to a major funding round that propelled its expansion across Russia. This influx of capital enabled Doc Plus to enhance its technological infrastructure and expand its service offerings, including telemedicine consultations and home healthcare services.
Despite facing challenges such as regulatory hurdles and competition from traditional healthcare providers, Doc Plus continued to innovate and adapt. The company's commitment to improving healthcare accessibility and quality earned it a loyal user base and recognition as a leader in the digital health space.
Today, Doc Plus stands as a testament to the power of innovation in transforming healthcare delivery. Its journey reflects the broader trend of digitalization in healthcare, offering valuable insights into the future of medical services in Russia and beyond.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Moscow, Russia
- Employees
- 232
- Open positions
- None listed
- Dealroom signal
- 70.8/100
- Industry
- Health
- Sub-industry
- Health Platform
- Sector
- Health Tech & Medtech, Testing, Telemedicine, Sustainable Development Goals, Tech for Patients, Hard Tech, Digital Care, medical testing
- Business model
- Marketplace & ecommerce
- Client focus
- b2c
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Aug 2018 | $9M | $36M | VNV Global | — |
| SERIES B✓Equity / VC | Jun 2017 | $5M | $20M | Baring Vostok Capital Partners · Yandex | ↗ |
Growth signals
Latest recorded traffic for Doc Plus is 490 monthly website visits, up 69% over the last three months. Doc Plus's team declined 1.3% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A3 investors entered at this stage
Yandex
Baring Vostok Capital Partners
VNV Global
Other known investors1 additional known investor
Michael (Misha) Sokolov
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Doc Plus on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Doc Plus’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







